Loading clinical trials...
Loading clinical trials...
Control-IQ Technology in Individuals With Type 2 Diabetes (2IQ)
Conditions
Interventions
Control-IQ technology 1.5
Locations
3
United States
Mayo Clinic
Rochester, Minnesota, United States
Icahn School of Medicine at Mt. Sinai
New York, New York, United States
Texas Diabetes and Endocrinology
Austin, Texas, United States
Start Date
November 30, 2021
Primary Completion Date
August 10, 2022
Completion Date
August 18, 2022
Last Updated
March 6, 2024
NCT06579404
NCT06311019
NCT05785832
NCT06268808
NCT05893797
NCT04585191
Lead Sponsor
Tandem Diabetes Care, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions